Summary:
In this session from DPHARM 2024, pharma experts in data science, digital innovation and development discuss the prerequisites for generative artificial intelligence (GenAI) to work well in large pharma organizations, the change management required to implement GenAI adoption, use cases and lessons learned, ensuring GenAI use is fit-for-purpose, and more.
For more information, go to DPHARMconference.com.
Moderators
Syed Waseem Haider, PhD
Head of Business, IT Partnership for AI
Merck & Co., Inc.
Speakers
Henry Wei, MD
Head of Development Innovation
Regeneron Pharmaceuticals Inc
Shameer Khader, PhD, MPH
Executive Director
Sanofi
Dave Apfel, MBA
Head, External Innovation, R&D Data Science and Digital Health
Johnson & Johnson
.PNG)
Sujata Shah, MBA
Senior Director, Medical Writing Delivery and Excellence
Moderna
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.